Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
0.660
+0.006 (0.92%)
Dec 20, 2024, 4:00 PM EST - Market closed
Passage Bio Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 41 | 55 | 75 | 344 | 1,164 | - | |
Market Cap Growth | 19.88% | -26.45% | -78.09% | -70.49% | - | - | |
Enterprise Value | -18 | -51 | -111 | -11 | 829 | - | |
Last Close Price | 0.66 | 1.01 | 1.38 | 6.35 | 25.57 | - | |
PB Ratio | 0.56 | 0.50 | 0.37 | 1.08 | 3.82 | - | |
P/TBV Ratio | 0.59 | 0.50 | 0.37 | 1.08 | 3.82 | - | |
Debt / Equity Ratio | 0.36 | 0.24 | 0.13 | - | - | - | |
Quick Ratio | 5.00 | 6.99 | 10.33 | 10.70 | 14.40 | 43.16 | |
Current Ratio | 5.15 | 7.22 | 10.74 | 11.02 | 14.98 | 45.04 | |
Return on Equity (ROE) | -69.15% | -65.29% | -52.35% | -59.48% | -46.85% | -44.46% | |
Return on Assets (ROA) | -30.85% | -32.67% | -27.00% | -32.52% | -27.61% | -21.63% | |
Return on Capital (ROIC) | -34.49% | -35.17% | -29.54% | -35.64% | -29.20% | -22.34% | |
Earnings Yield | -168.77% | -184.33% | -180.82% | -53.96% | -9.64% | - | |
FCF Yield | -144.88% | -141.62% | -160.04% | -42.06% | -7.01% | - | |
Buyback Yield / Dilution | -7.30% | -0.58% | -2.03% | -38.14% | -811.60% | -17.74% | |
Total Shareholder Return | -7.30% | -0.58% | -2.03% | -38.14% | -811.60% | -17.74% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.